Terazosin, doxazosin, and prazosin: current clinical experience
- 1 December 2001
- Vol. 58 (6) , 49-54
- https://doi.org/10.1016/s0090-4295(01)01302-4
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Use of recombinant α1-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophyPublished by Elsevier ,2003
- Benign prostatic hyperplasia: an overviewUrology, 1999
- Management of Symptomatic BPH in the US: Who Is Treated and How?European Urology, 1999
- The economics of benign prostatic hyperplasia treatment: a literature reviewClinical Therapeutics, 1996
- Benign prostatic hyperplasia: A review of its histogenesis and natural historyThe Prostate, 1996
- Benign Prostatic Hyperplasia — Medical and Minimally Invasive Treatment OptionsNew England Journal of Medicine, 1995
- Characterization and Localization of Prostatic Alpha 1 Adrenoceptors Using Radioligand Receptor Binding on Slide-Mounted Tissue SectionJournal of Urology, 1993
- This Month in Investigative Urology: Alpha Adrenergic Innervation of the Prostate: Insights into Pharmacotherapy of BPHJournal of Urology, 1990
- The Development of Human Benign Prostatic Hyperplasia with AgeJournal of Urology, 1984
- A Placebo‐controlled Double‐blind Study of the Effect of Phenoxybenzamine in Benign Prostatic ObstructionBritish Journal of Urology, 1978